Julian Gilbert joins Oracle Head & Neck Cancer UK as a trustee
Oracle Head & Neck Cancer UK is delighted to welcome Julian Gilbert to the charity as a trustee.
Julian Gilbert with Julie Child
Julian is the founder and managing director of Wealth Matters, a financial planning firm, and is a Certified Financial Planner and Chartered Wealth Manager.
Julian also has first-hand experience of Head and Neck Cancer. In early 2017, he was diagnosed with Throat Cancer after a persistent “tickle” in his throat. His treatment began in February 2017 at University College London Hospitals (UCLH) and consisted of six weeks of radiotherapy.
Writing about his treatment in 2017, Julian said: “I wouldn’t wish the treatment on my worst enemy. Head and Neck Cancer is tough – physically, mentally and emotionally.”
Fortunately, Julian’s cancer was diagnosed at an early stage. This meant that his prognosis was good and that, even though the treatment was more invasive than he’d expected, he was able to be optimistic that his life would carry on. On 30 June 2017, Julian was told he was cancer-free.
Following his diagnosis, treatment and recovery, Julian wanted to support a Head and Neck Cancer charity and help future patients to have a more comfortable experience.
Julian discovered Oracle following a recommendation from a specialist dietitian. He has supported the charity ever since, including through fundraising and awareness-raising.
Keith Jones
Keith Jones, Chair of the Board of Trustees at Oracle Head & Neck Cancer UK, said: “Julian has been a committed friend and supporter of Oracle for nine years. His lived experience and passion for our cause, coupled with his business and governance expertise, will be a real asset to our board, and we are very pleased to welcome him to the team.”
Julian Gilbert
Julian said: “Becoming a trustee at Oracle Head and Neck Cancer UK is a role that I’m very proud to take up. Oracle means a lot to me, having suffered throat cancer myself back in 2017. The medical treatment that I received then and subsequently has been second to none. I feel very privileged to still be alive and want to give back as much as I can. The fund raising that I did in 2017 and subsequently, not only helped the charity, but was a big part of my mental rehabilitation to move forward. I hope that I can help Oracle to give further support to patients and families fighting throat and neck cancer.”
Newsletter October 2026
Julie Child, Executive Director Last week, we held our annual Oncology Meeting in York, attended by 150 clinicians from across the UK. Being able to thank those who support our work was so valuable, and to hear about the progress being made behind the scenes to improve patient outcomes. Our research projects at Oxford, UCL,…
Martyn Dipper
In September 2021, I was sitting in a car outside a hospital having just been told I had T4 throat cancer. The tumour was too large to operate on. Within weeks I was offered a place on TORPEdO – the first clinical trial in the UK to study Proton Beam Therapy for throat cancer –…
Eating well after head and neck cancer treatment: join our November webinar
A specialist dietitian and a patient talk about food, swallowing and eating out after head and neck cancer treatment.
Thank you to our brilliant Great North Run runners!
This September, two incredible supporters took to the streets of Newcastle for the Great North Run, the world’s largest half marathon, and we couldn’t be prouder of them both. Beth Robinson Scales completed the 13.1-mile route in searing heat, raising over £3,800 for Oracle. Beth ran in honour of her husband Steve, following his recurrence, and…
Bringing the UK’s head and neck oncology community together
The Oracle Head & Neck Cancer UK Oncology Meeting 2026 takes place tomorrow, Friday 25th September, at The Milner Hotel, York. Now in its third year under the Oracle umbrella, this free educational meeting brings together head and neck oncology specialists from around 40 centres across the UK, spanning radiography, nursing, clinical and medical oncology,…
October Webinar: Immunotherapy & Other Developing Treatments
Professor Kevin Harrington explores the latest immunotherapy treatments for head and neck cancer in our upcoming webinar on 6 October.
Mark Hodgson walks 310km in August for Oracle Head and Neck Cancer UK
A Leeds private investigator who was treated for stage 4 cancer of the throat and tongue is walking 10 kilometres every day throughout August for Oracle Head & Neck Cancer UK. He has already passed his original £10,000 target, with 11 days of the challenge still to run. Mark Hodgson is a director of Tremark Associates, a Leeds…
September Webinar: Understanding Head & Neck cancer late effects in survivorship.
From cure to consequence:
Understanding Head & Neck cancer late effects in survivorship.
Thursday 10 September 2026
18:00 – 19:00 pm
Our Late Effects webinar will feature Sabina Khan and Emma Hallam, Macmillan Consultant Radiographers. Both specialise in head and neck post-treatment late effects. They’ll be joined by patient Karen Liesching-Schroder, who will share the patient perspective drawing on her experience of diagnosis, treatment and late effects.
Oracle launches new webinar series to support Head & Neck Cancer Patients
Oracle Head & Neck Cancer has launched its new webinar series for anyone newly diagnosed with head and neck cancer. First in the series ‘I’ve just been diagnosed. What now?” features retired Consultant Oncologist Professor Dr Mehmet Sen and patient speaker Hazel Turner. They share expert advice and personal experience to help patients and…
Newsletter June 2026
Julie Child, Executive Director It’s been a whirlwind five months since I started at Oracle Head and Neck Cancer UK. Thanks to your support and donations, the charity was successful in its Emergency Appeal and managed to secure the funds required to go forward. I’ve been very fortunate to meet a number of supporters, both…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 167-169, Great Portland Street, 5th Floor, London W1W 5PF.